Iran sees progress in knowledge-based pharmaceuticals
The Vice President of Research and Technology at the Ministry of Health, Treatment, and Medical Education announced that there are currently 800 research centers operating, including 52 centers specifically focused on pharmaceuticals. Additionally, there are 1,285 knowledge-based companies in the health sector.
These companies contribute to 40 percent of the production of raw materials and their growth has accelerated during the current administration, IRNA reported.
Younes Panahi shared this information during his speech at a three-day conference on the future of pharmaceuticals held at Olympic Hotel on Wednesday. He emphasized that scientific circles have recognized the significance of advancements in pharmaceuticals. Leading universities worldwide have prioritized meeting society’s healthcare needs through research endeavors.
Furthermore, Panahi stated that there are currently 257 scientists working in various health-related fields across our country, with 28 percent specializing in pharmaceuticals. Notably, first-rate scientific journals focus on pharmaceutical topics while researchers strive for scientific excellence within this field.
Panahi highlighted how pharmacy is highly regarded within scientific communities today as it addresses a crucial societal need for medicine and medical equipment. He emphasized that science cannot progress without financial resources.
Heydar Mohammadi, head of Iran’s Food and Drug Organization also addressed attendees at this conference by emphasizing Iran’s achievements despite harsh sanctions impacting its pharmaceutical industry. Mohammadi proudly stated that we now produce 99 percent of drugs domestically; even amidst COVID-19 pandemic challenges, six domestic corona vaccines were successfully developed—an impressive testament to our nation’s capabilities.
Mohammadi stressed that cell therapy discussions hold great importance as a significant portion of required raw materials is produced internally—underscoring further research efforts needed in this area to avoid neglecting its potential benefits.
Regarding export opportunities, he urged pharmaceutical manufacturers to support increased activity in this field. He expressed satisfaction with current growth but emphasized the need for continued expansion.
Pharmacists’ presence in hospitals was deemed necessary by the official as it aids patient treatment processes. Additionally, efforts are being made to address concerns related to medical service tariffs during the country’s 7th Development Plan to ensure pharmacists’ well-being is not compromised.
He also expressed hope that with pharmacists playing a vital role, our country would soon achieve complete drug self-sufficiency—realizing a fully functional production and supply chain for pharmaceutical items.
Mohammad Raieszadeh, head of the country’s top medical organization, stressed the criticality of considering future advancements in medical sciences and pharmaceuticals. Failing to keep up with these changes could lead us into a disadvantaged position within tomorrow’s world. Ignoring the importance of medicine and pharmaceuticals is not an option.
Raieszadeh further emphasized that pharmaceutical science and industry are strategic sectors within our nation. Therefore, it is crucial that we unite in supporting this industry rather than allowing other organizations to encroach upon its domain. The progress and development of Iran’s pharmaceutical industry should be championed alongside recognizing the contributions of professors and veterans who have dedicated their expertise towards advancing this field.